Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biodesix (BDSX) Equity Ratio (2019 - 2025)

Historic Equity Ratio for Biodesix (BDSX) over the last 7 years, with Q3 2025 value amounting to 0.02.

  • Biodesix's Equity Ratio fell 10715.85% to 0.02 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02, marking a year-over-year decrease of 10715.85%. This contributed to the annual value of 0.21 for FY2024, which is 36448.87% up from last year.
  • Latest data reveals that Biodesix reported Equity Ratio of 0.02 as of Q3 2025, which was down 10715.85% from 0.01 recorded in Q2 2025.
  • Biodesix's Equity Ratio's 5-year high stood at 0.32 during Q1 2021, with a 5-year trough of 0.09 in Q2 2023.
  • Moreover, its 5-year median value for Equity Ratio was 0.13 (2022), whereas its average is 0.12.
  • Within the past 5 years, the most significant YoY rise in Biodesix's Equity Ratio was 172728.45% (2024), while the steepest drop was 21203.7% (2024).
  • Biodesix's Equity Ratio (Quarter) stood at 0.26 in 2021, then dropped by 14.44% to 0.22 in 2022, then crashed by 79.16% to 0.05 in 2023, then surged by 364.49% to 0.21 in 2024, then tumbled by 109.04% to 0.02 in 2025.
  • Its last three reported values are 0.02 in Q3 2025, 0.01 for Q2 2025, and 0.13 during Q1 2025.